EKSO BIONICS HOLDINGS INC (EKSO) Stock Price, Quote, News and Overview
NASDAQ:EKSO - Nasdaq - US2826443010 - Common Stock - Currency: USD
EKSO Quote, Performance and Key Statistics
EKSO BIONICS HOLDINGS INC
NASDAQ:EKSO (2/10/2025, 8:00:01 PM)
Premarket: 0.5749 +0 (+0.05%)0.5746
+0.05 (+9.45%)
The current stock price of EKSO is 0.5746 USD. In the past month the price decreased by -27.17%. In the past year, price decreased by -71.83%.
EKSO Latest News and Analysis
NSM Named Exclusive Distributor of Ekso Indego® Personal Within the CRT Industry
Move expected to broaden access to Ekso Bionics’ portable exoskeleton device for individuals living with spinal cord injuries and other mobility challenges...
Ekso Bionics to Showcase Its Device Technology in ‘AI for Good’ Webinar on Tuesday, November 19
SAN RAFAEL, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton...
Ekso Bionics to Participate at the 15th Annual Craig-Hallum Alpha Select Conference
SAN RAFAEL, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton...
Ekso Bionics Announces Third Quarter 2024 Financial Results
SAN RAFAEL, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton...
EKSO Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.12 | 227.75B | ||
| ISRG | INTUITIVE SURGICAL INC | 81.27 | 212.18B | ||
| BSX | BOSTON SCIENTIFIC CORP | 42.3 | 156.49B | ||
| SYK | STRYKER CORP | 32.21 | 149.67B | ||
| MDT | MEDTRONIC PLC | 17.3 | 116.48B | ||
| BDX | BECTON DICKINSON AND CO | 17.44 | 66.57B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.63 | 41.93B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.73 | 39.98B | ||
| IDXX | IDEXX LABORATORIES INC | 41.33 | 38.07B | ||
| RMD | RESMED INC | 26.99 | 35.02B | ||
| DXCM | DEXCOM INC | 51.92 | 34.48B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 20.74 | 25.93B |
Related stock screener links
About EKSO
Company Profile
Ekso Bionics Holdings, Inc. engages in the design, development and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company is headquartered in San Rafael California, California and currently employs 70 full-time employees. The company went IPO on 2013-04-10. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton; Ekso Indego Personal is a lightweight powered lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The firm enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate and to walk again; assist individuals with a range of upper extremity impairments and allow industrial workers to perform difficult repetitive work for extended periods. Its segments include EksoHealth and EksoWorks.
Company Info
EKSO BIONICS HOLDINGS INC
101 Glacier Point, Suite A
San Rafael California CALIFORNIA 94804 US
CEO: Jack Peurach
Employees: 71
Company Website: https://eksobionics.com/
Investor Relations: https://ir.eksobionics.com/
Phone: 15109841761
EKSO FAQ
What is the stock price of EKSO?
The current stock price of EKSO is 0.5746 USD.
What is the symbol for EKSO BIONICS HOLDINGS INC stock?
The exchange symbol of EKSO BIONICS HOLDINGS INC is EKSO and it is listed on the Nasdaq exchange.
On which exchange is EKSO stock listed?
EKSO stock is listed on the Nasdaq exchange.
Is EKSO a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for EKSO, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of EKSO.
Does EKSO stock pay dividends?
EKSO does not pay a dividend.
When does EKSO stock report earnings?
EKSO will report earnings on 2025-02-27, after the market close.
What is the Price/Earnings (PE) ratio of EKSO?
EKSO does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.65).
What is the Short Interest ratio of EKSO stock?
The outstanding short interest for EKSO is 7.32% of its float.
EKSO Technical Analysis
EKSO Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to EKSO. EKSO has a bad profitability rating. Also its financial health evaluation is rather negative.
EKSO Financial Highlights
Over the last trailing twelve months EKSO reported a non-GAAP Earnings per Share(EPS) of -0.65. The EPS decreased by 41.96% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -38.11% | ||
| ROE | -74.86% | ||
| Debt/Equity | 0.28 |
EKSO Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to EKSO. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 53.64% and a revenue growth -1.84% for EKSO